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Abstract
Background: Artemisia macrocephala Jacquem (A. macrocephala), locally known as “Tarkha”, is a perennial plant
found abundantly in northern areas of Pakistan. It is widely used in traditional medicine to treat fever, pain,
gastrointestinal disorders and diabetes. Till date, no published studies are available regarding the in-vivo
antinociceptive potential of the crude extract and sub-fractions from the aerial parts of A. macrocephala.
Methods: Antinociceptive effects of the crude methanolic extract and its sub-fractions were assessed using
experimental pain models, including chemical nociception induced by intraperitoneal acetic acid or subplantar
formalin injection and thermal nociception like tail immersion test in-vivo.
Results: The administration of various doses of crude extract and its fractions showed a dose-dependent indomethacin
like antinociceptive effect in acetic acid induced writhing, subplantar formalin injection animal model suggesting the
involvement of central mechanism of pain inhibition. Moreover, the crude extract and sub-fractions, on tail flick model
(thermal nociception) demonstrated the involvement of central mechanism and significantly increased the latency time
to 66.54, 82.94 and 70.53 %. The antagonistic study proposed the possible involvement of opioid receptor using
naloxone as non-selective antagonist. The pharmacologically active chloroform and ethyl acetate fractions were
further subjected to column chromatography that lead to the isolation four compounds. These isolated compounds
were then subjected to various spectroscopic techniques upon which they were confirmed to be one sterol and three
flavonoid derivatives. These findings suggest that Artemisia macrocephala possesses peripheral and central analgesic
potentials partially associated with opioid system that support its folkloric use for the management of pain.
The isolated compounds are currently under investigation in our laboratory for analgesic activity and its possible
mechanism of action.
Conclusion: The results in this study provide evidences that A. macrocrphala has anticonciceptive effects and can be
used for treatment of pain in traditional therapies. This study opens a new channel for isolation of analgesic
compounds from the specie that is used traditionally for the management of pain.
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Background
Despite of the present scientific advancement in pain
therapies, potent, safe and effective drugs are still needed
for many painful conditions [1]. The current available
therapies for pain, mostly elicit severe adverse effects
[2, 3]. Therefore, drugs with no such effects are searched
throughout the world [4]. Natural products like plants,
animals, microbes and marine life have contributed to
almost 50 % of current drugs that are used as a significant
tool for the management of various ailments [5]. Searches
from the past have led to the discovery of active analgesic
from plants in shape of aspirin and morphine [6, 7].
The genus Artemisia has diverse uses in traditional
system of medicine. Its members are used for abdominal
pains and colds in the head, as expectorant for bron-
chitis and asthma, as poultice for rheumatoid arthritis,
and as a plaster cast for broken bones [8]. Scientifically,
many of its plants had been reported to possess anti-
inflammatory, insecticidal, analgesic, antispasmodic, an-
tifungal, antibacterial and photo protective [9], while
some of its species are used during labor pain [10]. On
scientific basis, Artemisia herba alba had been proved to
have clear antinociceptive and anti-inflammatory effects
[11], Artemisia copa presents antinociceptive and topical
anti-inflammatory [12], Artemisia absinthium possesses
topical analgesic [13] and Artemisia dracunculus has
significant analgesic and anti-inflammatory effects [14]. Dif-
ferent classes of chemicals, e.g., coumarins, terpenes, ses-
quiterpenes, flavonoids, aromatics, dipeptides, phenolics,
coumarins, esterols, germacranolides, guaianolides, seco-
guaianolides and polysaccharides have been isolated
from Artemisia species [15]. These constituents impart a
wide-range of pharmacological effects like analgesic
[16–19] antitumoral, antioxidant, anti-inflammatory
[17–19] anti-cancer and immunomodulatory action
[20–23]. Some species of this genus are used in bev-
erages and in infusions for their digestive properties,
serves as a base for some bitter drinks while its oils
possess trypanocydal and mosquito repellent proper-
ties [24]. A. macrocephala Jacquem is an important
member of this genus which is found abundantly in
Northern Areas of Pakistan [25]. The preliminary
phytochemical investigations confirmed the presence
of terpenes, flavonoids, saponins and alkaloids [26].
Our previous work on this specie revealed its trad-
itional use for the management of gut spasms and
confirmed its antispasmodic response using in vitro
rabbits’ jejunal preparations. Apart from that, it also
possesses antioxidant activity [25]. In another study,
our group worked on its enzyme inhabiting potentials
and confirmed that its essential oil obtained by
process of hydro distillation has significant enzyme
inhibition activity against acetylcholinesterase and
butyrylcholinesterase activity that may be a possible
alternative for treating Alzheimer’s disease [27]. Apart
from other folkloric uses, this specie is known for its
anti-inflammatory and analgesic response; therefore,
the present study was designed to explore on scien-
tific basis the traditional use of A.macrocephala for
possible antinociceptive potential using animal model.
The finding of this study may further lead to the investiga-
tion for the isolation and structure elucidation of bioactive
compounds responsible for its anti-inflammatory and
analgesic activities.
Methods
Collection and authentication of plant materials
Fresh aerial parts of A. macrocephala were collected in
August, 2014 from the nearby hills of Badwan Chowk,
Dir Lower, Khyber Pakhtunkhwa, Pakistan. The species
was identified by plant taxonomist, Dr. Nasur Ullah,
Assistant Professor University of Malakand Chakdara
Dir Lower Khyber Pakhtunkhwa, Pakistan. A voucher
specimen “Am-01–2014” was submitted to the herbarium
of Department of Botany, University of Malakand.
Extraction
The plant material was kept in shade at room temperature
for drying. It was afterwards crushed and pulverized by a
mechanical grinder to obtain fine powder. The fine pow-
der (5.5 kg) was then macerated in commercial grade
methanol with occasional shaking for 22 days at room
temperature. The materials were then filtered off. The
process was repeated 3 times. The filtrates were combined
and evaporated under reduced pressure, using a rotary
evaporator, until a dark greenish color crudemethanolic
extract (Am.Cme) was obtained.
Fractionation
The crude Am.Cme. (500 g, 9.09 %) was suspended in dis-
tilled water (400 mL), which was successively fractionated
with 400 mL of n-hexane. The process was repeated until
complete fractionation. Similar procedure was followed
for fractionation with chloroform and ethyl acetate till it
successively gave 44 g of n-hexane fraction (Am.n-hex,
8.8 %), 77 g of chloroform fraction (Am.Chf, 15.4 %),
40.4 g of ethyl acetate (Am.EtOAc, 8.08 %) and 32 g of
residual aqueous fraction (Am.Aq, 6.4 %). The fractions
were refrigerated till pharmacological screenings.
Preliminary phytochemical screening and isolation of
compounds
Based upon our previous findings of various phytochem-
icals in the crude extract [25], the subsequent fractions
were subjected to preliminary phytochemical screening
to explore the natural product rich fraction. Further, the
pharmacologically active fractions (chloroform and ethyl
acetate) were subjected to column chromatography for
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isolation of active chemical constituents that were fur-
ther subjected to various spectroscopic techniques like
mass, 1H-NMR, NOESY, COSY, HMBC and HSQC for
structure elucidation.
Animals and ethical approval
Animals used, were Swiss albino mice of either sex. They
were obtained from animal house of Department of
Pharmacy, University of Malakand, Chakdara, Dir Lower,
KPK, Pakistan. They were maintained under standard
conditions of laboratory and were fed standard food and
water ad libitum. All the protocols of the experiment
were approved by ethical committee of Department of
Pharmacy (No: E-AM-01–2009), University of Malakand
as per Bye Laws 2008 of the University of Malakand
(Scientific Procedures Issue-I).
Acute toxicity
The crude methanolic extract and fractions were tested
for acute toxicity study as per standard protocol [28].
Swiss albino mice were administered 500, 1000, 1500
and 2000 mg/kg of the crude extract and fractions per
oral route. One group received normal saline that served
as negative control. The animals were observed for 6 h
continuously for changes in their behavior. Mortality for
the next 14 days was also noted.
Analgesic activity
Acetic acid induced writhing test
The peripheral antinociceptive response is determined
through acetic acid induced writhing test.
Two groups of mice (n = 6) for each sample were pre-
pared. They were given 150 and 300 mg/kg of crude ex-
tract and 100 and 200 mg/kg (orally) of sub-fractions
1 h before the injection of 10 mL/kg of 1 % acetic acid
intraperitoneally. Negative control group was given
10 mL/kg of 1 % solution of Tween 80 (1 %, v/v) while
positive control group was given 50 mg/kg of diclofenac
sodium intraperitoneally to overnight fasting mice.
Writhing and stretching number was noted and percent
protection was determined from the data [29].
Formalin test
This test was carried out as per Pandurangan et al. [30]
protocol with a bit modification. Five mice per group were
given different doses (150 and 300 mg/kg crude and 100
and 200 mg/kg sub-fraction) of test samples. After 30 min
of administration of test samples, 2.5 % formalin (20 μl)
was injected subcutaneously (s.c) in mice’ hind paw. The
time spent in licking of the test paw (to which test samples
were injected) in early phase (0–5 min) and late phase
(15–30 min) were recorded. Naloxone, opioid antagonist
(2 mg/kg, s.c), standard drug indomethacin (10 mg/kg)
and Tween 80 (2 %, v/v) were also used.
Tail immersion test
In order to determine the central antinociceptive response
of the test samples, the animals were given different doses
(150 and 300 mg/kg crude and 100 and 200 mg/kg sub-
fraction) of the sample intraperitoneally, 2 % vehicle and
50 mg/kg of diclofenac sodium, 30 min prior to the
immersion of the tail (3 cm) into hot water (55 ± 0.5 °C). To
assess the possible involvement of opioid receptors, mor-
phine (agonist) in a dose of 5.0 mg and naloxone (antagon-
ist) in a dose of 2.0 mg were used. The time of reaction
taken at 15, 30, 45, 60, 75 and 90 min after administration
of test samples were noted using a stopwatch [31].
Statistical analysis
Data are presented as mean ± SEM (n = 6). Graph Pad
Prism was used for analysis of data followed by Dunnett’s
test for statistical significance using p ≤ 0.05.
Results
Results for the preliminary phytochemical screening
reveal the presence of flavonoids and saponins in the
chloroform fraction and sterol and flavonoid in the
ethyl acetate fraction. The chloroform fraction was
found to be rich with flavonoids. Apart from flavo-
noids, saponins and terpenes were also present but
in mild quantity. The pharmacologically active frac-
tions (chloroform and ethyl acetate) lead to the iso-
lation of four compounds. The integration of the
isolated compounds Ism-1 to Ism-4 are summarized
as under, while the original spectra are given in
Additional file 1.
Ism-1
Pale yellow amorphous powder, IR (KBr, Cm−1), 3391,
3263, 1659, 1519. UV λMeOH max nm: 342 and 347;
1H-
NMR (500 MHz, CD3OD): δ 7.59 (d, 1H, J6′,5′ = 8.0 Hz,
H-6′), 7.10 (br s, 1H, H-2′), 7.09 (d, 1H, J5′,6′ = 8.0 Hz,
H-5′), 6.63 (s, 1H, H-2), 6.52 (s, 1H, H-8), 3.92 (s, 3H,
H-4′/OCH3), 3.90 (s, 3H, H-3′/OCH3), 3.86 (s, 3H, H-6/
OCH3), δ EI-MS: m/z 344 (M
+), 329, 326, 301 [32].
Ism-2
Light yellow amorphous powder, 1H-NMR (500 MHz,
acetone-d6) δ 12.98 (s, 1H, H-5/OH), 7.96 (d, 2H, J2′,3′/
6′,5′ = 8.0 Hz, H-2/H-6), 7.03 (d, 2H, J3′,2′/5′,6′ = 8.0 Hz,
H-3/H-5), 6.68 (s, 1H, H-3), 6.66 (d, 1H, J8,6 = 2.0 Hz, H-
8), 6.32 (d, 1H, J6,8 = 2.0 Hz, H-6), 3.92 (s, 3H, H-4′/
OCH3). EI MS m/z (%) 284 (M
+), 255 [33].
Ism-3
Slight yellow powder, IR (KBr, Cm−1), 3500, 1662, 1614,
1512. UV (AlCl3 +MeOH): λmax: 484 (2.86), 272 (2.79) and
1H-NMR (500 MHz, MeOD) δ 6.18 (1H, d, J= 2.0 Hz, H-
6), 6.39 (1H, d, J = 2.0 Hz, H-8), 6.88 (1H, d, J= 8.3 Hz, H-
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5′), 7.62 (1H, dd, J = 8.3; 2.1 Hz, H-6′), 7.74 (1H, d, J
= 2.1 Hz, H-2′, ESI-MS: m/z 300.9 [M-H]-, 602.6
[2 M-H] [34].
Ism-4
White, waxy powder, IR (KBr, Cm−1), 3373.6, 2940.7, 2867.9,
1641.6, 1457.3, 1381.6, 1038.7, 881.6. UV λ CHCl3 max nm:
220. 1H-NMR (500 MHz, CDCl3) δ (ppm) = 0.74 (1H, s, H-
18), 0.87 (1H, d, J= 6.9 Hz, H-27), 0.88 (1H, d, J= 6.9 Hz,
H-26), 0.89 (1H, t, J= 7.4 Hz, H-29), 0.93 (1H, d, J= 6.5 Hz,
H-21), 0.97 (1H, m, H-24), 0.98 (1H, m, H-9), 1.04 (1H, m,
H-14), 1.06 (1H, s, H-19), 1.07 (1H, m, H-22b), 1.11 (1H,
tm, J= 11.2 Hz, H-15b), 1.13 (1H, m, H-1b), 1.16 (1H, t, J =
10.0 Hz, H-17), 1.21 (1H, m, H-23), 1.21 (1H, m, H-12b),
1.30 (1H, m, H-16b), 1.31 (1H, m, H-28), 1.36 (1H, m, H-
22a), 1.40 (1H, m, H-20), 1.50 (1H, qd, J= 10.8; 4.6 Hz, H-
11b), 1.50 (1H, m, H-7), 1.55 (1H, m, H-11a), 1.56 (1H, m,
H-2b), 1.63 (1H, m, H-15a), 1.71 (1H, m, H-25), 1.88 (1H,
m, H-2a), 1.89 (1H, m, H-16a), 1.90 (1H, m, H-1a), 2.03 (1H,
td, J= 12.1; 2.4 Hz, H-8), 2.06 (1H, dt, J= 12.8; 3.6 Hz, H-
12a), 2.30 (1H, td, J = 11.0; 2.0 Hz, H-4b), 2.34 (1H,
ddd, J = 13.0; 5.0; 2.0 Hz, H-4a), 3.58 (1H, tt, J = 11.3;
5.3 Hz, H- 3), 5.40 (1H, dd, J = 5.2; 2.3 Hz, H-6); ESI-
MS: m/z:437 [M + Na] + [35].
The crude methanolic extract and sub-fractions in test
doses of 500, 1000, 1500 and 2000 mg/kg body weight
showed no adverse effects on the behavioral responses
in the tested mice following 14 days observation. No
mortality or weight change observed. Therefore, a high-
est dose of 300 mg/kg given to mice in this study was
considered to be safe.
In performing the acetic acid induced writhing test
for the determination of antinociceptive effect, the
samples showed a significant analgesic effect. The
crude methanolic extract, chloroform and ethyl acetate
fraction showed a dose dependent response and signifi-
cantly inhibited the acetic acid induced writhings with a
maximum value of 62.64 % (P < 0.01, n = 6), 71.88 %
(P < 0.001, n = 6) and 66.93 % (P < 0.001, n = 6), respect-
ively as shown in Table 1. Whereas, the residual aqueous
fraction showed no significant activity (data not shown).
All the results were compared against standard (diclofenac
sodium, 50 mg/kg) with 84.96 % response.
After the administration of the crude extract and its
sub-fractions to the animals treated with formalin, it
showed a dose dependent response and significantly
inhibited both the phases with 37.93 % (**P < 0.01, n = 6),
51.34 % (***P < 0.001, n = 6) and 45.33 (**P < 0.01, n = 6) in
the first phase and 56.87 % (***P < 0.001, n = 6), 73.54 %
(***P < 0.001, n = 6) and 66.63 % (**P < 0.01, n = 6) of crude
methanolic extract (300 mg/kg), chloroform and ethyl
acetate fraction (200 mg/kg) respectively, for the second
phase. While the aqueous fraction showed no any promin-
ent response (data not shown).
Animals treated with morphine (5.0 mg) significantly
inhibited both the phases with 86.86 % (***P < 0.001, n = 6)
and 96.11 % (***P < 0.001, n = 6) for first phase and second
phase respectively as shown in Table 2. A reversal of in-
hibitory potential was observed in animals pre-treated
with naloxone.
The results show that naloxone caused a prominent
reversal effect of the analgesic potential of morphine in
both the phases. Indomethacin (10 mg/kg) mildly inhib-
ited the first phase with 20.38 % (***P < 0.001, n = 6) and
significantly inhibited the second phase with 74.08 %
(***P < 0.001, n = 6).
The samples (crude methanolic extract 300 mg/kg,
chloroform 200 mg/kg and ethyl acetate fraction
200 mg/kg) when tested for its effectiveness in tail flick
model, significantly increased the latency time to
66.54 % (**P < 0.01, n = 6), 82.94 % (**P < 0.01, n = 6) and
70.53 % (***P < 0.001, n = 6) respectively at 60 min at
which morphine (opioid analgesic, centrally acting),
showed 85.07 % (***P < 0.001, n = 6) activity resembling
more to that of the chloroform fraction. Naloxone
Table 1 Acetic acid induced analgesic activity of test samples
of Artemisia macrocephala
Treatment/dose Number of writhings % inhibition
Control (2 % Tween 80) 67.59 ± 1.02 —
Crd 150 mg 300 mg 31.63±1.25** 53.20
25.25±1.05** 62.64
Chf 100 mg 200 mg 27.25±1.20** 59.68
19.00 ± 1.35*** 71.88
EtOA 100 mg 200 mg 28.45±1.15** 57.90
22.35±1.20** 66.93
Diclofenac sodium (50 mg) 10.16±0.70*** 84.96
All the values were expressed as mean ±SEM (n=6). **P<0.01, ***P<0.001 when
compared to control group
Key: Crd crude methanolic extract, chf chloroform fraction, EtOA ethyl
acetate fraction
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treated animals significantly reduced the analgesic po-
tentials of morphine and the test samples (Table 3).
Discussion
There are many natural products that are used in trad-
itional medicines in various countries. Alternative sys-
tem of medicine for various ailments is receiving much
more attention. Many plants produce significant effect(s)
like synthetic drug(s) [36]. Therefore, natural products
with little side effects are compulsory to take place of
chemical therapeutics [37]. Data from the literature
showed that some species of the genera Artemisia
possess analgesic activity and these pharmacological
effects have been attributed mainly to flavonoids, alka-
loids, sesquiterpene lactones and essential oils [38].
The main focus of our work is to confirm on scientific
basis that A. macrocephala possesses antinociceptive ac-
tivity. This conclusion is strengthened by three different
methods used for the evaluation of antinociceptive activ-
ity. The results obtained from this study showed the
presence of antinociceptive potentials of A. macroce-
phala in all animal models used. Acetic acid induced
abdominal constriction is a quite sensitive practice that
enables the detection of peripheral antinociceptive activ-
ity [9]. This test causes localized inflammation in mice
due to biosynthesis of prostaglandins and leukotriens
through cyclooxygenase and lipooxygenase pathway [39].
This model is based on several nociceptive mechanisms,
like sympathetic system (biogenic amines release),
cyclooxygenases and their metabolites [40] and opioid
mechanisms [41]. Therefore, the formalin and tail
immersion tests were used to find out if the plant pos-
sesses any central analgesic potential.
The formalin test is considered a valid model for clin-
ical pain [42] and in this model; the crude extract and
sub-fractions effectively inhibited the licking response in
both early and late phases, in a manner more similar to
that of morphine. An opioid antagonist, naloxone,
greatly reversed the analgesic effect of the crude extract
and sub-fractions indicating that opioid receptors are
involved in the activity. However, complete antagonism
was not observed, therefore, it may be concluded that
the effect was due to flavonoids [43], as the plant tested
positive for the presence of flavonoids [25].
In tail flick test the crude extract and sub-fractions
again showed morphine like response indicating that the
crude extract and sub-fractions have spinal effect.
NSAIDs (Non-steroidal anti-inflammatory drugs) act by
decreasing the sensitivity of pain receptors which is
caused by prostaglandins [44]. Though the exact mech-
anism is not known, the observed activity may be due to
morphine like effect of the samples. A lot of substances
Table 2 To show effects of Artemisia macrocephala on formalin-induced paw-licking response
Treatment/dose Licking Time (sec) Inhibition (%)
1st phase 2nd phase 1st phase 2nd phase
Control (2 % Tween 80) 50.03 ± 1.63 72.00 ± 1.30 ——
Crd 150 mg 34.22±1.12** 37.25±1.619** 31.60 48.26
300 mg 31.05±1.125** 31.05±1.668*** 37.93 56.87
Chf 100 mg 28.25±1.65** 30.50±1.425** 43.53 57.63
200 mg 24.34±1.411*** 19.05±1.039*** 51.34 73.54
EtOA 100 mg 28.96±1.55** 30.95±1.441*** 42.11 57.01
200 mg 27.35 ±1.05** 24.02 ±0.95** 45.33 66.63
Indomethacin (10 mg) 39.83±1.55** 18.66±1.542*** 20.38 74.08
Morphine (5 mg) 6.41±1.165*** 2.83±1.260*** 86.86 96.11
N + Crd 150 mg 47.15±1.75 63.60±1.542 5.75 11.66
300 mg 47.70±1.50 64.50±1.428 4.65 10.41
N + Chf 100 mg 47.80±1.25 65.35±1.30 4.45 9.30
200 mg 48.05±1.33 66.65±1.45 3.95 7.43
N + EtOA 100 mg 47.75±1.23 64.85±1.40 4.55 9.93
200 mg 47.95±1.25 65.95±1.416 4.15 8.40
N+ Indomethacin (10 mg) 44.00±1.84** 25.00 ±1.539*** 12.05 65.27
N + Morphine (5 mg) 47.66±1.52 71.83±1.142 2.39 1.37
All the values were expressed as mean ±SEM. *P<0.05, **P<0.01 and ***P<0.001 whencompared to control group (one way ANOVA followed by Dunnett’s:
compare all vscontrol test)
Key: Crd crude methanolic extract, chf chloroform fraction, EtOA ethyl acetate fraction, N naloxone 2 mg
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with spinal analgesic activity are present in literature
among which the most familiar one is morphine [45]. In
a similar way, we tried to find out on scientific basis the
antinociceptive potentials of A. macrocephala, which
showed morphine like antinociceptive activity, which
increases the list of pharmacological activities already
mentioned for A. macrocephala. This discovery encour-
ages our previous work of relaxant activity of the crude
extract and essential oil of A. macrocephala [25]. More-
over, flavonoids are polyphenolic compounds and are
plant’s secondary metabolites. They are becoming the
focus of medical research since they possess useful prop-
erties like antiviral [46], anti-inflammatory, antitumour,
antiallergic, antimicrobial, antioxidant, cytotoxic, enzyme
inhibition, oestrogenic [47, 48], vasodilating [49], anti-
pyretic and analgesic activities [50]. Based upon the
above findings (Tables 1, 2 and 3), and the pharmaco-
logical potentials of flavonoids, the pharmacologically
rich chloroform and ethyl acetate fractions were sub-
jected to column chromatography for the isolation of
active bio molecules. These bio-molecules (Ism-1, Ism-2,
Ism-3 and Ism-4) are currently under scientific investi-
gations for possible analgesic activity and its mechanistic
approach to determine the involvement of various
receptors apart from opioid receptor that play important
role in nociception. This ongoing research will
standardize the specie for bio-guided isolation of tar-
geted pharmacologically active moieties.
Conclusion
The results show that A. macrocephala is rich with bio-
active compounds producing analgesic effect. A. macro-
cephala can be further investigated for the isolation and
structure elucidation of the bioactive compounds re-
sponsible for analgesic activity and to explore its possible
mechanism of action.
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Additional file 1: Spectra analysis. (DOC 6349 kb)
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